Cancer Tumor Profiling Market Scope And Analysis

  • Report Code : TIPRE00003122
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse de la dynamique et de la portée du marché du profilage du cancer et des tumeurs d'ici 2025-2031

Buy Now

Cancer/Tumor Profiling Market Report Cancer/Tumor Profiling Market Size and Share Cancer/Tumor Profiling Market Scope and Analysis

Cancer/Tumor Profiling Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 10.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Technologie
  • immunoessais
  • hybridation
  • techniques de séquençage
  • spectrométrie de masse
By Type de cancer
  • cancer du poumon
  • cancer du sein
  • cancer colorectal
  • cancer de la prostate
  • mélanome
By Demande
  • demande clinique et demande de recherche
By Géographie
  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina, Inc.
  • QIAGEN N.V.
  • NeoGenomics Laboratories, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Genomic Health Inc.
  • Caris Life Sciences
  • Helomics Corporation
  • NanoString Technologies, Inc.
  • Sysmex Corporation